Skip to main content
HairCited

Minoxidil के लिए Androgenetic Alopecia

A

191 अध्ययनों (19 meta-analyses, 21 RCTs) पर आधारित, में कुल 41,495 प्रतिभागियों के साथ। 159/191 अध्ययन सकारात्मक प्रभाव दिखाते हैं।

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

निष्कर्ष

Minoxidil is strongly supported by extensive research as an effective option that may help promote hair regrowth in people with androgenetic alopecia.

  • 191 studies with over 41,000 participants — one of the most researched hair loss ingredients
  • 83% of studies show positive effects on hair regrowth and density
  • Both topical and oral forms are supported by meta-analyses and RCTs
  • Recent expert consensus guidelines support its use as a first-line option

Key Study Findings

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 बनाम: Placebo प्रभाव: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: women with androgenetic alopecia (female pattern hair loss)

Other
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern …
Dose: MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day बनाम: None Outcome: consensus recommendations for managing pattern hair loss प्रभाव: None None

जनसंख्या: hair transplant patients with male and female pattern hair loss (Delphi panel consensus)

non-randomized controlled trial n=60 16 weeks Open-label
Clinical Efficacy and Mechanisms of Microneedling Alone or Combined With Drugs in the Treatment of …
Dose: Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); बनाम: Placebo प्रभाव: All groups showed significant decrease in HLSS and increase in hair density post-treatment (p<0.001) p<0.001
Case Reports n=1 Open-label
Plica Neuropathica (Polonica) Secondary to Diffuse Alopecia: A Case Report and Literature Review.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: 62-year-old female with diffuse alopecia and plica neuropathica

review
Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current …
Dose: varies by agent and study बनाम: Placebo प्रभाव: variable; oral antiandrogens demonstrate some efficacy; topical antiandrogens possibly fewer systemi None

Key Statistics

299

अध्ययन

68291

प्रतिभागी

Positive

A

ग्रेड

Referenced Papers

American journal of … 2026 1 उद्धरण
Journal of the … 2026
Aesthetic plastic surgery 2025 14 उद्धरण
Expert opinion on … 2025 11 उद्धरण
Frontiers in bioengineering … 2025 8 उद्धरण
Anais brasileiros de … 2025 7 उद्धरण
Drug design, development … 2025 7 उद्धरण
Acta dermato-venereologica 2025 4 उद्धरण
Therapeutic delivery 2025 4 उद्धरण
European journal of … 2025 3 उद्धरण
Australian prescriber 2025 2 उद्धरण
Frontiers in pharmacology 2025 2 उद्धरण
Journal of cutaneous … 2025 2 उद्धरण
Acta dermatovenerologica Alpina, … 2025 2 उद्धरण
International journal of … 2025 1 उद्धरण
Journal of clinical … 2025 1 उद्धरण
Skin appendage disorders 2025 1 उद्धरण
Nature reviews. Disease … 2025
Archives of dermatological … 2025
Annals of dermatology 2025
International journal of … 2024 39 उद्धरण
Indian journal of … 2024 14 उद्धरण
Journal of cosmetic … 2024 11 उद्धरण
Lasers in medical … 2024 10 उद्धरण
Journal of clinical … 2024 10 उद्धरण
Facial plastic surgery … 2024 8 उद्धरण
Photodermatology, photoimmunology & … 2024 8 उद्धरण
Journal of cosmetic … 2024 8 उद्धरण
American family physician 2024 8 उद्धरण
Skin health and … 2024 7 उद्धरण
International journal of … 2024 5 उद्धरण
Dermatology reports 2024 4 उद्धरण
Life (Basel, Switzerland) 2024 4 उद्धरण
SAGE open medical … 2024 3 उद्धरण
Vestnik oftalmologii 2024 1 उद्धरण
Drugs 2023 221 उद्धरण
JAAD international 2023 80 उद्धरण
Clinical, cosmetic and … 2023 58 उद्धरण
American journal of … 2023 41 उद्धरण
Anais brasileiros de … 2023 29 उद्धरण
Skin appendage disorders 2023 27 उद्धरण
Journal of the … 2023 20 उद्धरण
Archives of dermatological … 2023 16 उद्धरण
Journal der Deutschen … 2023 5 उद्धरण
International journal of … 2023 5 उद्धरण
Journal of cosmetic … 2023 3 उद्धरण
BMJ case reports 2023 2 उद्धरण
Dermatologic surgery : … 2023 2 उद्धरण
Clinics in plastic … 2023 1 उद्धरण
International journal of … 2023 1 उद्धरण
The Journal of … 2022 170 उद्धरण
Faculty reviews 2022 44 उद्धरण
Dermatology and therapy 2022 43 उद्धरण
Dermatologic therapy 2022 41 उद्धरण
Pharmaceutics 2022 36 उद्धरण
Journal of cosmetic … 2022 35 उद्धरण
The Korean journal … 2022 19 उद्धरण
Dermatologic therapy 2022 14 उद्धरण
Clinical and experimental … 2022 9 उद्धरण
Journal of cosmetic … 2022 7 उद्धरण
Cureus 2022 3 उद्धरण
Facial plastic surgery … 2022
Journal of the … 2021 203 उद्धरण
Journal of cutaneous … 2021 44 उद्धरण
Journal of the … 2021 42 उद्धरण
Actas dermo-sifiliograficas 2021 3 उद्धरण
Expert opinion on … 2020 147 उद्धरण
American journal of … 2020 127 उद्धरण
International journal of … 2020 58 उद्धरण
Dermatologic therapy 2020 34 उद्धरण
Indian dermatology online … 2020 31 उद्धरण
American journal of … 2020 24 उद्धरण
Dermatologic clinics 2020 15 उद्धरण
Facial plastic surgery … 2020 15 उद्धरण
Alternative therapies in … 2020 11 उद्धरण
Drug design, development … 2019 320 उद्धरण
Journal of cosmetic … 2019 100 उद्धरण
American journal of … 2019 84 उद्धरण
Journal of cosmetic … 2019 34 उद्धरण
Expert opinion on … 2019 34 उद्धरण
Bioscience, biotechnology, and … 2019 9 उद्धरण
International journal of … 2018 129 उद्धरण
Journal of the … 2018 114 उद्धरण
Indian journal of … 2018 79 उद्धरण
Lasers in medical … 2018 75 उद्धरण
Dermatologic therapy 2018 63 उद्धरण
Journal of cosmetic … 2018 13 उद्धरण
Australian journal of … 2018 8 उद्धरण
American family physician 2017 141 उद्धरण
JAMA dermatology 2017 121 उद्धरण
Current clinical pharmacology 2017 62 उद्धरण
Lasers in medical … 2017 43 उद्धरण
Actas dermo-sifiliograficas 2017 17 उद्धरण
BMJ case reports 2017 6 उद्धरण
Deutsches Arzteblatt international 2016 99 उद्धरण
The Cochrane database … 2016 18 उद्धरण
Dermatologic therapy 2015 72 उद्धरण
The Medical clinics … 2015 66 उद्धरण
Seminars in cutaneous … 2015 27 उद्धरण
Current problems in … 2015 8 उद्धरण
Der Internist 2015
Lasers in surgery … 2014 243 उद्धरण
Journal of cutaneous … 2014 168 उद्धरण
Expert opinion on … 2014 57 उद्धरण
Skin therapy letter 2014 29 उद्धरण
Journal of drugs … 2014 26 उद्धरण
Giornale italiano di … 2014 8 उद्धरण
Giornale italiano di … 2014
Indian journal of … 2013 196 उद्धरण
Dermatologic clinics 2013 78 उद्धरण
Journal of cosmetic … 2013 62 उद्धरण
International journal of … 2013 61 उद्धरण
Indian journal of … 2013 16 उद्धरण
Facial plastic surgery … 2013 16 उद्धरण
International journal of … 2013
Skin therapy letter 2012 100 उद्धरण
The British journal … 2012 48 उद्धरण
The Cochrane database … 2012 15 उद्धरण
The British journal … 2011 96 उद्धरण
Expert opinion on … 2010 264 उद्धरण
Indian journal of … 2009 109 उद्धरण
Current opinion in … 2009 54 उद्धरण
Seminars in cutaneous … 2009 4 उद्धरण
American family physician 2009
Current opinion in … 2008 31 उद्धरण
Nihon rinsho. Japanese … 2008 6 उद्धरण
Endocrinology and metabolism … 2007 33 उद्धरण
The Australasian journal … 2007 32 उद्धरण
Clinical interventions in … 2007
Acta dermatovenerologica Alpina, … 2005
Annual review of … 2004 664 उद्धरण
Revue medicale de … 2004
The journal of … 2003 102 उद्धरण
Praxis 2003 28 उद्धरण
American family physician 2003 2 उद्धरण
American family physician 2003
Clinical and experimental … 2002 61 उद्धरण
Therapeutische Umschau. Revue … 2002 4 उद्धरण
American journal of … 2000 18 उद्धरण
Southern medical journal 2000
International journal of … 1999 16 उद्धरण
Journal of cutaneous … 1999
Journal of the … 1999
International journal of … 1999
American family physician 1999
Dermatologic clinics 1998 121 उद्धरण
Annales de dermatologie … 1997
Journal of the … 1984

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

topical:
2-5% solution, twice daily

अधिकतम सीमा: 5% topical solution

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
None -- Neutral --
MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day -- Positive --
Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); 16 weeks Positive 60
None -- Mixed 1
varies by agent and study -- Positive --
None -- Positive --
None -- Mixed --

सेवन का सर्वोत्तम समय: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

ज्ञात अंतःक्रियाएँ

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

सहनीय अधिकतम सेवन: 5% topical solution

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Minoxidil help with Androgenetic Alopecia?
Based on 299 studies with 68,291 participants, there is strong evidence from multiple clinical trials that Minoxidil may support Androgenetic Alopecia management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for Androgenetic Alopecia?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and Androgenetic Alopecia?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 299 peer-reviewed studies with 68,291 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Androgenetic Alopecia

Minoxidil अन्य स्वास्थ्य स्थितियों के लिए

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।